PRKG1 and intrahepatic cholangiocarcinoma: Taken together, PKG inhibitors do not appear to be suitable for in situ studies, and genetic models with combinations of deleted genes and expression of optogenetic sensors appear to be needed for future studies to address downstream signaling mechanisms responsible for neural regulation of ICC.